FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sanford Krantz

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Procedures

Colony Forming Units Assays

Disorders

Living Beings

Concepts & Ideas

Kinetics

Co-author Network

Publications

TOP 3
Xuesong Xu; Qi Zhang; Jian Luo; Shu Xing; Qingshan Li; Sanford B Krantz; Xueqi Fu; Zhizhuang Joe Zhao
JAK2(V617F): Prevalence in a large Chinese hospital population.
Zhizhuang Joe Zhao; William Vainchenker; Sanford B Krantz; Nicole Casadevall; Stefan N Constantinescu
Role of tyrosine kinases and phosphatases in polycythemia vera.
Runxiang Zhao; Shu Xing; Zhe Li; Xueqi Fu; Qingshan Li; Sanford B Krantz; Zhizhuang Joe Zhao
Identification of an acquired JAK2 mutation in polycythemia vera.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sanford Krantz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Xuesong Xu; Qi Zhang; Jian Luo; Shu Xing; Qingshan Li; Sanford B Krantz; Xueqi Fu; Zhizhuang Joe Zhao
JAK2(V617F): Prevalence in a large Chinese hospital population.
Blood 2007;109(1):339-42.
2005: Zhizhuang Joe Zhao; William Vainchenker; Sanford B Krantz; Nicole Casadevall; Stefan N Constantinescu
Role of tyrosine kinases and phosphatases in polycythemia vera.
Seminars in hematology 2005;42(4):221-9.
2005: Runxiang Zhao; Shu Xing; Zhe Li; Xueqi Fu; Qingshan Li; Sanford B Krantz; Zhizhuang Joe Zhao
Identification of an acquired JAK2 mutation in polycythemia vera.
The Journal of biological chemistry 2005;280(24):22788-92.
2005: Chunhua Dai; Ik-Joo Chung; Sanford B Krantz
Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
Experimental hematology 2005;33(2):152-8.
2004: Chunhua Dai; Ik-Joo Chung; Sanford B Krantz
In human immature BFU-E tumor necrosis factor-alpha not only downregulates CDK6 but also directly produces apoptosis which is prevented by stem cell factor.
Experimental hematology 2004;32(10):911-7.
2003: Ming-Jiang Xu; Xingwei Sui; Runxiang Zhao; Chunhua Dai; Sanford B Krantz; Zhizhuang Joe Zhao
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.
Blood 2003;102(13):4354-60.
2003: Runxiang Zhao; Xueqi Fu; Qingshan Li; Sanford B Krantz; Zhizhuang Joe Zhao
Specific interaction of protein tyrosine phosphatase-MEG2 with phosphatidylserine.
The Journal of biological chemistry 2003;278(25):22609-14.
2003: Chunhua Dai; Ik-Joo Chung; Shazi Jiang; James O Price; Sanford B Krantz
Reduction of cell cycle progression in human erythroid progenitor cells treated with tumour necrosis factor alpha occurs with reduced CDK6 and is partially reversed by CDK6 transduction.
British journal of haematology 2003;121(6):919-27.
2003: Ik-Joo Chung; Chunhua Dai; Sanford B Krantz
Stem cell factor increases the expression of FLIP that inhibits IFNgamma -induced apoptosis in human erythroid progenitor cells.
Blood 2003;101(4):1324-8.
2002: Ying Qi; Runxiang Zhao; Hongxi Cao; Xingwei Sui; Sanford B Krantz; Zhizhuang Joe Zhao
Purification and characterization of protein tyrosine phosphatase PTP-MEG2.
Journal of cellular biochemistry 2002;86(1):79-89.
2001: Chunhua Dai; Sanford B Krantz
Increased expression of the INK4a/ARF locus in polycythemia vera.
Blood 2001;97(11):3424-32.
2000: Xingwei Sui; Sanford B Krantz; Zhizhuang Joe Zhao
Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
British journal of haematology 2000;110(1):63-70.
1999: R Shan; James O Price; William A Gaarde; Brett P Monia; Sanford B Krantz; Zhizhuang Joe Zhao
Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin.
Blood 1999;94(12):4067-76.
1999: Chunhua Dai; Sanford B Krantz
Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells.
Blood 1999;93(10):3309-16.
1998: Sanford B Krantz
Southern society for clinical investigation founders medal recipient's address.
The American journal of the medical sciences 1998;316(5):329-34.
1998: Xingwei Sui; Sanford B Krantz; M You; Z Zhao
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
Blood 1998;92(4):1142-9.
1998: CH Dai; James O Price; T Brunner; Sanford B Krantz
Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis.
Blood 1998;91(4):1235-42.
1997: S Taniguchi; CH Dai; James O Price; Sanford B Krantz
Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells.
Blood 1997;90(6):2244-52.
1997: Xingwei Sui; Sanford B Krantz; Z Zhao
Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells.
Blood 1997;90(2):651-7.
1997: CH Dai; Sanford B Krantz; S T Sawyer
Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera.
Blood 1997;89(10):3574-81.
1997: S Taniguchi; CH Dai; Sanford B Krantz
Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Experimental hematology 1997;25(3):193-8.
1996: M C Bondurant; T Yamashita; K Muta; Sanford B Krantz; Mark J Koury
C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Journal of cellular physiology 1996;168(2):255-63.
1996: Robert T Means; Sanford B Krantz
Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor.
Experimental hematology 1996;24(2):204-8.
1995: CH Dai; Sanford B Krantz; K Kollar; James O Price
Stem cell factor can overcome inhibition of highly purified human burst-forming units-erythroid by interferon gamma.
Journal of cellular physiology 1995;165(2):323-32.
1995: K Muta; Sanford B Krantz; M C Bondurant; CH Dai
Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation.
Blood 1995;86(2):572-80.
1995: K Muta; Sanford B Krantz
Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells.
Journal of cellular physiology 1995;163(1):38-50.
1994: Richard S Stein; R T Means; Sanford B Krantz; J M Flexner; John P Greer
Treatment of aplastic anemia with an investigational antilymphocyte serum prepared in rabbits.
The American journal of the medical sciences 1994;308(6):338-43.
1994: CH Dai; Sanford B Krantz; Stephen Thomas Koury; K Kollar
Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cells.
British journal of haematology 1994;88(3):497-505.
1994: Z L Chu; Amittha Wickrema; Sanford B Krantz; J C Winkelmann
Erythroid-specific processing of human beta spectrin I pre-mRNA.
Blood 1994;84(6):1992-9.
1994: Amittha Wickrema; Stephen Thomas Koury; CH Dai; Sanford B Krantz
Changes in cytoskeletal proteins and their mRNAs during maturation of human erythroid progenitor cells.
Journal of cellular physiology 1994;160(3):417-26.
1994: David Robertson; Sanford B Krantz; Italo Biaggioni
The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production.
Acta astronautica 1994;33():137-41.
1994: K Muta; Sanford B Krantz; M C Bondurant; Amittha Wickrema
Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells.
The Journal of clinical investigation 1994;94(1):34-43.
1994: Sanford B Krantz
Pathogenesis and treatment of the anemia of chronic disease.
The American journal of the medical sciences 1994;307(5):353-9.
1994: R T Means; Sanford B Krantz; J Luna; S A Marsters; A Ashkenazi
Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin.
Blood 1994;83(4):911-5.
1994: CH Dai; Sanford B Krantz; W F Green; H S Gilbert
Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression.
British journal of haematology 1994;86(1):12-21.
1993: R T Means; Sanford B Krantz
Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon.
The Journal of clinical investigation 1993;91(2):416-9.
1992: Amittha Wickrema; Sanford B Krantz; J C Winkelmann; M C Bondurant
Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells.
Blood 1992;80(8):1940-9.
1992: R T Means; Sanford B Krantz
Progress in understanding the pathogenesis of the anemia of chronic disease.
Blood 1992;80(7):1639-47.
1992: CH Dai; Sanford B Krantz; E N Dessypris; R T Means; S T Horn; H S Gilbert
Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Blood 1992;80(4):891-9.
1992: R T Means; E N Dessypris; Sanford B Krantz
Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon.
Journal of cellular physiology 1992;150(1):59-64.
1991: R T Means; Sanford B Krantz
Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin.
Blood 1991;78(10):2564-7.
1991: CH Dai; Sanford B Krantz; K M Zsebo
Human burst-forming units-erythroid need direct interaction with stem cell factor for further development.
Blood 1991;78(10):2493-7.
1991: Amittha Wickrema; M C Bondurant; Sanford B Krantz
Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells.
Blood 1991;78(9):2269-75.
1991: Richard S Stein; R I Abels; Sanford B Krantz
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes.
Blood 1991;78(7):1658-63.
1991: R T Means; E N Dessypris; Sanford B Krantz
Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response.
British journal of haematology 1991;78(1):114-9.
1991: E W Cotton; R T Means; S M Cline; Sanford B Krantz
Quantitation of insulin-like growth factor-I binding to highly purified human erythroid colony-forming units.
Experimental hematology 1991;19(4):278-81.
1991: F L Thompson; J S Powers; S E Graber; Sanford B Krantz
Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease.
The American journal of medicine 1991;90(3):398-400.
1991: CH Dai; Sanford B Krantz; R T Means; S T Horn; H S Gilbert
Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3.
The Journal of clinical investigation 1991;87(2):391-6.
1991: Sanford B Krantz
Erythropoietin.
Blood 1991;77(3):419-34.
1991: T Hosoi; Stephen T Sawyer; Sanford B Krantz
Photoaffinity labeling of the erythropoietin receptor and its identification in a ligand-free form.
Biochemistry 1991;30(2):329-35.
1991: T Hosoi; Stephen T Sawyer; William David Hankins; Sanford B Krantz
Binding studies on the erythropoietin receptor.
Contributions to nephrology 1991;88():59-69; discussion 70.
1990: R T Means; E N Dessypris; Sanford B Krantz
Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells.
The Journal of clinical investigation 1990;86(2):538-41.
1990: Theodore Pincus; Nancy J Olsen; Irwin Russell; F Wolfe; E R Harris; T J Schnitzer; J A Boccagno; Sanford B Krantz
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis.
The American journal of medicine 1990;89(2):161-8.
1990: Sanford B Krantz
Review of patients' responses to epoetin alfa therapy.
Pharmacotherapy 1990;10(2 ( Pt 2)):15S-21S.
1990: ALAN BAER; E N Dessypris; Sanford B Krantz
The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis.
Seminars in arthritis and rheumatism 1990;19(4):209-23.
1990: K Sawada; Sanford B Krantz; CH Dai; Stephen Thomas Koury; S T Horn; A D Glick; Curt I Civin
Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors.
Journal of cellular physiology 1990;142(2):219-30.
1990: E N Dessypris; Sanford B Krantz
Erythropoietin: regulation of erythropoiesis and clinical use.
Advances in pharmacology (San Diego, Calif.) 1990;21():127-47.
1990: Sanford B Krantz; K Sawada
Growth of highly purified human CFU-E in serum-free medium.
Progress in clinical and biological research 1990;352():9-20.
1990: Sanford B Krantz; S T Sawyer; K Sawada; F Wolfe; J Bocagno
Erythropoietin: receptors and clinical use in rheumatoid arthritis.
International journal of cell cloning 1990;8 Suppl 1():181-95; discussion 195-8.
1990: CH Dai; Sanford B Krantz; R T Means; S T Horn; H S Gilbert
Increased sensitivity of polycythemia vera blood burst-forming units-erythroid to interleukin 3.
Transactions of the Association of American Physicians 1990;103():249-57.
1989: R T Means; Sanford B Krantz; Stephen T Sawyer; H S Gilbert
Erythropoietin receptors in polycythemia vera.
The Journal of clinical investigation 1989;84(4):1340-4.
1989: S E Graber; Sanford B Krantz
Erythropoietin: biology and clinical use.
Hematology/oncology clinics of North America 1989;3(3):369-400.
1989: Stephen T Sawyer; Sanford B Krantz; K Sawada
Receptors for erythropoietin in mouse and human erythroid cells and placenta.
Blood 1989;74(1):103-9.
1989: R T Means; Nancy J Olsen; Sanford B Krantz; E N Dessypris; S E Graber; W J Stone; V L O'Neil; Theodore Pincus
Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies.
Arthritis and rheumatism 1989;32(5):638-42.
1989: K Sawada; Sanford B Krantz; E N Dessypris; Stephen Thomas Koury; Stephen T Sawyer
Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development.
The Journal of clinical investigation 1989;83(5):1701-9.
1988: E Dessypris; S E Graber; Sanford B Krantz; W J Stone
Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo.
Blood 1988;72(6):2060-2.
1988: Sanford B Krantz; Stephen T Sawyer; K I Sawada
Purification of erythroid progenitor cells and characterization of erythropoietin receptors.
The British journal of cancer. Supplement 1988;9():31-5.
1988: K Sawada; Sanford B Krantz; Stephen T Sawyer; Curt I Civin
Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells.
Journal of cellular physiology 1988;137(2):337-45.
1988: R T Means; Sanford B Krantz; E N Dessypris; JN Lukens; G D Niblack; John P Greer; J M Flexner; Richard S Stein
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum.
The American journal of medicine 1988;84(4):678-82.
1988: Sanford B Krantz; Stephen T Sawyer; K Sawada
The role of erythropoietin in erythroid cell differentiation.
Contributions to nephrology 1988;66():25-37.
1987: ALAN BAER; E N Dessypris; E Goldwasser; Sanford B Krantz
Blunted erythropoietin response to anaemia in rheumatoid arthritis.
British journal of haematology 1987;66(4):559-64.
1987: Sanford B Krantz; K Sawada; Stephen T Sawyer; Curt I Civin
Specific binding of erythropoietin to human erythroid colony-forming cells.
Transactions of the Association of American Physicians 1987;100():164-72.
1982: Mark J Koury; M C Bondurant; D T Duncan; Sanford B Krantz; William David Hankins
Specific differentiation events induced by erythropoietin in cells infected in vitro with the anemia strain of Friend virus.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(2):635-9.
1981: T A Kost; Mark J Koury; Sanford B Krantz
Mature erythroid burst-forming units are target cells for Friend virus-induced erythroid bursts.
Virology 1981;108(2):309-17.
1980: T A Kost; William David Hankins; A D Glick; Sanford B Krantz
Production of spleen focus-forming virus and murine leukemia virus by early erythroblasts after Friend virus infection.
Cancer research 1980;40(4):1150-6.
1980: T A Kost; William David Hankins; Sanford B Krantz
Combined effect of friend polycythemia virus and erythropoietin on erythroid burst formation in vitro.
Experimental hematology 1980;8 Suppl 8():248-58.
1980: William David Hankins; Sanford B Krantz; T A Kost; Mark J Koury
In vitro transformation of mouse hematopoietic cells by the spleen focus-forming virus.
Cold Spring Harbor symposia on quantitative biology 1980;44 Pt 2,():1211-4.